138 related articles for article (PubMed ID: 21155943)
21. Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
Andersen K; Weinberger MH; Constance CM; Ali MA; Jin J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):157-67. PubMed ID: 19617271
[TBL] [Abstract][Full Text] [Related]
22. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
23. Use of aliskiren in a 'real-life' model of hypertension management: analysis of national Web-based drug-monitoring system in Italy.
Volpe M; Tocci G; Bianchini F; De Rosa M; Fedozzi E; Covezzoli A; Maggioni AP;
J Hypertens; 2012 Jan; 30(1):194-203. PubMed ID: 22157325
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension.
Verdecchia P; Calvo C; Möckel V; Keeling L; Satlin A
Blood Press; 2007; 16(6):381-91. PubMed ID: 18058456
[TBL] [Abstract][Full Text] [Related]
25. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.
Strasser RH; Puig JG; Farsang C; Croket M; Li J; van Ingen H
J Hum Hypertens; 2007 Oct; 21(10):780-7. PubMed ID: 17541390
[TBL] [Abstract][Full Text] [Related]
28. Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients.
Siddiqi L; Oey PL; Blankestijn PJ
Nephrol Dial Transplant; 2011 Sep; 26(9):2930-4. PubMed ID: 21467128
[TBL] [Abstract][Full Text] [Related]
29. Effects of high- and low-sodium diets on ambulatory blood pressure in patients with hypertension receiving aliskiren.
Weir MR; Yadao AM; Purkayastha D; Charney AN
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):356-63. PubMed ID: 20876343
[TBL] [Abstract][Full Text] [Related]
30. Modelling of blood pressure outcomes in patients with and without established cardiovascular or renal disease following treatment with valsartan (the PREVIEW study).
Macdonald K; Brié H; Vancayzeele S; Lee C; Bowles J; Piotrowski K; Hermans C; Abraham I
Arch Cardiovasc Dis; 2013 Mar; 106(3):124-34. PubMed ID: 23582674
[TBL] [Abstract][Full Text] [Related]
31. Aliskiren-based stepped-care treatment algorithm provides effective blood pressure control.
Richter D; Mickel C; Acharya S; Brunel P; Militaru C
Int J Clin Pract; 2011 May; 65(5):613-23. PubMed ID: 21489085
[TBL] [Abstract][Full Text] [Related]
32. An observational, prospective, open-label, multicentre evaluation of aliskiren in treated, uncontrolled patients: a real-life, long-term, follow-up, clinical practice in Italy.
Tocci G; Aimo G; Caputo D; De Matteis C; Di Napoli T; Granatelli A; Lentini P; Magagna A; Matarrese AA; Perona D; Villa G; Volpe M;
High Blood Press Cardiovasc Prev; 2012 Jun; 19(2):73-83. PubMed ID: 22867093
[TBL] [Abstract][Full Text] [Related]
33. Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome.
Fogari R; Zoppi A; Mugellini A; Lazzari P; Derosa G
Horm Metab Res; 2010 Nov; 42(12):892-6. PubMed ID: 20814848
[TBL] [Abstract][Full Text] [Related]
34. Gender-specific, multi-level determinants of outcomes of antihypertensive treatment: a sub-analysis of the Belgian PREVIEW study.
MacDonald K; Lee CS; Chen HC; Ko ML; Fidel GE; Brié H; Hermans C; Vancayzeele S; Reel S; Van der Niepen P; Abraham I
J Hum Hypertens; 2011 Jun; 25(6):372-82. PubMed ID: 20631740
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction.
Ito S; Nakura N; Le Breton S; Keefe D
Hypertens Res; 2010 Jan; 33(1):62-6. PubMed ID: 19927154
[TBL] [Abstract][Full Text] [Related]
36. Impact of prolonged antihypertensive duration of action on predicted clinical outcomes in imperfectly adherent patients: comparison of aliskiren, irbesartan and ramipril.
Burnier M; Brede Y; Lowy A
Int J Clin Pract; 2011 Feb; 65(2):127-33. PubMed ID: 21208354
[TBL] [Abstract][Full Text] [Related]
37. Aliskiren: renin inhibitor for hypertension management.
Cheng JW
Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
[TBL] [Abstract][Full Text] [Related]
38. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Smith B; Weissbach N; Maboudian M; Botha J; van Ingen H
Circulation; 2009 Jan; 119(3):417-25. PubMed ID: 19139391
[TBL] [Abstract][Full Text] [Related]
39. Aliskiren reduces morning blood pressure in hypertensive patients with diabetic nephropathy.
Takenaka T; Nobe K; Okayama M; Kojima E; Nodaira Y; Sueyoshi K; Hoshi H; Watanabe Y; Takane H; Suzuki H
Clin Exp Hypertens; 2012; 34(4):243-8. PubMed ID: 22559034
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and safety of aliskiren and aliskiren hydrochlorothiazide (HCT) in a multiethnic, real-world setting.
Maddury SR; Pande A; Haque KM; Echtay A; Go L; Gulzar T; Kadwa M; Hristoskova S
Adv Ther; 2013 Feb; 30(2):176-89. PubMed ID: 23354585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
